Scarica l'app Stockscreener
227.45
1.85%
4.13
Dopo l'orario di chiusura:
227.97
0.52
+0.23%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Abbvie Inc Borsa (ABBV) Ultime notizie
AbbVie (NYSE:ABBV) Stock Price Up 1.9%Time to Buy? - MarketBeat
AbbVie (ABBV) Gains As Market Dips: What You Should Know - Yahoo Finance
AbbVie (ABBV) Stock in December 2025: Atogepant Breakthrough, Q3 Beat and 2026 Outlook After Medicare Price Cuts - ts2.tech
AbbVie (ABBV) Stock News and Forecasts Today: BofA Cuts Price Target to $233 as Wall Street Debates 2026 Pipeline Catalysts - ts2.tech
AbbVie’s (ABBV) Options Flow Implies That the Smart Money Could Be Up to Something - Barchart.com
AbbVie’s Growth Story Faces A Pipeline Pause - Finimize
The Power of Partnership: An Innovative Approach to Improve Maternal Health - AbbVie
AbbVie's Upside Potential Limited in Pipeline-Light 2026, BofA Securities Says - marketscreener.com
Valeo Financial Advisors LLC Sells 29,989 Shares of AbbVie Inc. $ABBV - MarketBeat
Texas Permanent School Fund Corp Sells 46,907 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Hold Rating: Balancing Growth Opportunities with Valuation and Pipeline Challenges - TipRanks
Orion Porfolio Solutions LLC Purchases 16,520 Shares of AbbVie Inc. $ABBV - MarketBeat
Stonebridge Wealth Management LLC Purchases New Stake in AbbVie Inc. $ABBV - MarketBeat
Thrivent Financial for Lutherans Purchases 125,719 Shares of AbbVie Inc. $ABBV - MarketBeat
Marex Group plc Acquires Shares of 5,914 AbbVie Inc. $ABBV - MarketBeat
Rep. Julie Johnson Sells Off Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. $ABBV Shares Acquired by Geneos Wealth Management Inc. - MarketBeat
American Trust Has $4.43 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
AbbVie Ranked #15 in the Inaugural Fortune 100 Best Companies to Work For Southeast Asia 2025 List - PR Newswire
AbbVie (ABBV) Stock: What to Know Before the US Market Opens on December 15, 2025 - ts2.tech
MASTERINVEST Kapitalanlage GmbH Makes New $12.37 Million Investment in AbbVie Inc. $ABBV - MarketBeat
AbbVie’s New Study on Parkinson’s Treatment: What Investors Need to Know - TipRanks
Kentucky Retirement Systems Sells 7,443 Shares of AbbVie Inc. $ABBV - MarketBeat
North Dallas Bank & Trust Co. Invests $1.68 Million in AbbVie Inc. $ABBV - MarketBeat
Public Sector Pension Investment Board Has $165.77 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever. - The Motley Fool
Advisory Services Network LLC Grows Position in AbbVie Inc. $ABBV - MarketBeat
Assessing AbbVie (ABBV) Valuation After HSBC Upgrade, Strong Earnings, and Dividend Hike - Yahoo Finance UK
My Top 3 Healthcare Stocks to Buy in 2026 - Finviz
AbbVie Inc. $ABBV Shares Acquired by Curi Capital LLC - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by Engineers Gate Manager LP - MarketBeat
BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 59,257 Shares of AbbVie Inc. $ABBV - MarketBeat
Bridgeway Capital Management LLC Purchases Shares of 110,140 AbbVie Inc. $ABBV - MarketBeat
Bellevue Group AG Boosts Stock Position in AbbVie Inc. $ABBV - MarketBeat
Benjamin Edwards Inc. Grows Stock Position in AbbVie Inc. $ABBV - MarketBeat
Ameriprise Financial Inc. Sells 3,127,890 Shares of AbbVie Inc. $ABBV - MarketBeat
Adage Capital Partners GP L.L.C. Lowers Position in AbbVie Inc. $ABBV - MarketBeat
Is AbbVie stock too cheap to ignore at today's price? - MSN
CapEx per share of AbbVie, Inc. – BX:4AB - TradingView — Track All Markets
AbbVie Stock (ABBV) After-Hours Update: What Happened on Dec. 12, 2025—and What to Watch Before the Next Market Open - ts2.tech
ABBV Stock News: Lenz Therapeutics Faces Setback with FDA Report - GuruFocus
Morgan Stanley Maintains Overweight Rating on ABBV, Raises Price Target to $269 | ABBV Stock News - GuruFocus
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 - Finviz
Morgan Stanley Adjusts Price Target on AbbVie to $269 From $261, Maintains Overweight Rating - marketscreener.com
AbbVie Slipped Below 50-Day SMA Last Week: How to Play the Stock - Finviz
Treasurer of the State of North Carolina Sells 27,645 Shares of AbbVie Inc. $ABBV - MarketBeat
HSBC upgrades AbbVie (ABBV) to buy, raises price target to $265 - MSN
AbbVie Inc. $ABBV Shares Bought by Quantinno Capital Management LP - MarketBeat
Hamilton Capital LLC Cuts Holdings in AbbVie Inc. $ABBV - MarketBeat
Peapack Gladstone Financial Corp Acquires 20,164 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Nebula Research & Development LLC - MarketBeat
Canada Pension Plan Investment Board Has $466.58 Million Stake in AbbVie Inc. $ABBV - MarketBeat
Diversify Advisory Services LLC Purchases 10,883 Shares of AbbVie Inc. $ABBV - MarketBeat
Bayesian Capital Management LP Sells 4,700 Shares of AbbVie Inc. $ABBV - MarketBeat
Alliancebernstein L.P. Increases Stake in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025) - ts2.tech
Hot Picks: Large-cap health care stocks to watch for dividend growth - BNN Bloomberg
Is AbbVie Stock Too Cheap to Ignore at Today's Price? - sharewise.com
Botox maker quietly launches plan to fend off rivals - Yahoo Finance
'This is a great opportunity to get, what we call, a dividend growing stock': Nesbitt on Abbvie Inc. - BNN Bloomberg
$73 Billion Non-Opioid Therapeutics Industry Assessment, 2032 Featuring AbbVie, GlaxoSmithKline, Acorda Therapeutics, Allay Therapeutics, Alnylam Pharmaceuticals and Other Key Players - Yahoo Finance
Here's How AbbVie's Oncology Drugs are Aiding Top-line Growth - The Globe and Mail
Glenview Trust co Has $78.24 Million Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
The Manufacturers Life Insurance Company Raises Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Scotiabank Sticks to Their Buy Rating for AbbVie (ABBV) - The Globe and Mail
1.22%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):